
Partnering
-
Hitachi Chemical
Hitachi Chemical has recently obtained the license for Accelltas latest media which is devoid of human/animal derived components and comprised only of artificially synthesized substances, offering a high level of safety that is key to the success of regenerative medicine.
http://www.hitachi-chem.co.jp
STEMCELL Technologies
Accellta granted exclusive worldwide rights for micro-carrier free stem cells suspension culture to STEMCELL Technologies.
http://www.stemcell.com/
Ajinomoto Co.
Accellta has granted worldwide non-exclusive rights to Ajinomoto Co. Inc. for manufacturing and distribution of proprietary cell culture medium and ancillary products and methods.
http://www.ajinomoto.com/en/
EMD Millipore
Accellta has granted worldwide non-exclusive rights to EMD Millipore for manufacturing and distribution of proprietary cell culture medium and ancillary products and methods.
http://www.emdmillipore.com/